Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?

Lorenzo Pini, Simone Lista, Alessandra Griffa, Gilles Allali, Bruno P Imbimbo

Open source

DOI
10.1093/braincomms/fcae460
Published
2024-12-18
Container
Brain Communications
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/braincomms/fcae460,
  title = {Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?},
  author = {Lorenzo Pini and Simone Lista and Alessandra Griffa and Gilles Allali and Bruno P Imbimbo},
  year = {2024},
  journal = {Brain Communications},
  doi = {10.1093/braincomms/fcae460},
  url = {https://doi.org/10.1093/braincomms/fcae460}
}

RIS

TY  - JOUR
TI  - Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?
AU  - Lorenzo Pini
AU  - Simone Lista
AU  - Alessandra Griffa
AU  - Gilles Allali
AU  - Bruno P Imbimbo
PY  - 2024
JO  - Brain Communications
DO  - 10.1093/braincomms/fcae460
UR  - https://doi.org/10.1093/braincomms/fcae460
ER  - 

APA

Pini, L., Lista, S., Griffa, A., Allali, G., & Imbimbo, B. P. (2024). Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?. Brain Communications. https://doi.org/10.1093/braincomms/fcae460

Source records